Cytokine-induced Memory-like Natural Killer Cell Therapy After Hematopoietic Stem Cell Transplantation for Eradication of Measurable Residual Disease, a Phase I/Ib Clinical Trial

Conditions: Acute Myeloid Leukemia; Leukemia; Leukemia, Myeloid; Myelodysplastic Syndromes; Myeloproliferative Neoplasm; Myeloproliferative Disorders Interventions: Biological: Cytokine Induced Memory-like Natural Killer Cells; Biological: Interleukin-2 Sponsors: Dana-Farber Cancer Institute Not yet recruiting

https://clinicaltrials.gov/study/NCT06138587

Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials